drugset
drugset / Trial / NCT03216447

A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant

NCT03216447 ↗

Phase 4 Unknown 150 enrolled Chang Gung Memorial Hospital Astellas Pharma Taiwan, Inc. · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

A study of patient adherence and convenience to immunosuppressive agents in newly liver transplant recipients - a prospective, multi-center, open-labeled, randomized clinical trial for comparison between once-daily early conversion and twice-daily tacrolimus formulation.

Timeline

Start
2017-11-23
Primary completion
2023-08-31
Completion
2025-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule — —

Indications

No indication recorded.